{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:06Z","timestamp":1786119366833,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/dad.0b013e3181a9070d","type":"journal-article","created":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T04:46:02Z","timestamp":1257914762000},"page":"794-798","source":"Crossref","is-referenced-by-count":23,"title":["A Histological Examination for Skin Atrophy After 6 Months of Treatment With Fluocinolone Acetonide 0.01%, Hydroquinone 4%, and Tretinoin 0.05% Cream"],"prefix":"10.1097","volume":"31","author":[{"given":"Jag","family":"Bhawan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearl","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Keady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh R","family":"Byers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian L","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz E","family":"Col\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210202","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","article-title":"The treatment of melasma: a review of clinical trials.","volume":"55","author":"Gupta","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R2-13-20210202","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1540-9740.2005.04285.x","article-title":"A practical comparison of hydroquinone-containing products for the treatment of melasma.","volume":"4","author":"Abramovits","year":"2005","journal-title":"Skinmed"},{"key":"R3-13-20210202","first-page":"153","article-title":"Cost-effectiveness of a fixed combination of hydroquinone\/tretinoin\/fluocinolone cream compared with hydroquinone alone in the treatment of melasma.","volume":"6","author":"Cestari","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"R4-13-20210202","first-page":"169","article-title":"Rationale for the use of topical corticosteroids in melasma.","volume":"3","author":"Menter","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"R6-13-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00128071-200607040-00003","article-title":"A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.","volume":"7","author":"Torok","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"R7-13-20210202","first-page":"67","article-title":"Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.","volume":"72","author":"Taylor","year":"2003","journal-title":"Cutis"},{"key":"R8-13-20210202","first-page":"934","article-title":"Topical steroid abuse: its use as a depigmenting agent.","volume":"98","author":"Nnoruka","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"R9-13-20210202","first-page":"592","article-title":"A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.","volume":"4","author":"Torok","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"R10-13-20210202","first-page":"57","article-title":"Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.","volume":"75","author":"Torok","year":"2005","journal-title":"Cutis"},{"key":"R11-13-20210202","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archderm.1991.01680040074006","article-title":"Effects of tretinoin on photodamaged skin: a histological study.","volume":"127","author":"Bhawan","year":"1991","journal-title":"Arch Dermatol"},{"key":"R12-13-20210202","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1365-4362.1998.00433.x","article-title":"Short- and long-term histologic effects of topical tretinoin on photodamaged skin.","volume":"37","author":"Bhawan","year":"1998","journal-title":"Int J Dermatol"},{"key":"R13-13-20210202","first-page":"25","article-title":"Assessment of the long-term safety of topical retinoids.","volume":"75","author":"Bhawan","year":"2005","journal-title":"Cutis"},{"key":"R14-13-20210202","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM199308193290803","article-title":"Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid).","volume":"329","author":"Griffiths","year":"1993","journal-title":"N Engl J Med"},{"key":"R15-13-20210202","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/1523-1747.ep12476385","article-title":"Topical all-trans retinoic acid stimulates collagen synthesis in vivo.","volume":"96","author":"Schwartz","year":"1991","journal-title":"J Invest Dermatol"},{"key":"R16-13-20210202","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.1988.03720040019020","article-title":"Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study.","volume":"259","author":"Weiss","year":"1988","journal-title":"JAMA"},{"key":"R17-13-20210202","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdermsci.2007.01.009","article-title":"The vascular characteristics of melasma.","volume":"46","author":"Kim","year":"2007","journal-title":"J Dermatol Sci"},{"key":"R18-13-20210202","first-page":"17","article-title":"Telangiectatic melasma: a new entity?","volume":"20","author":"Rendon","year":"2007","journal-title":"Cosmet Dermatol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000372-200912000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:07:48Z","timestamp":1786039668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000372-200912000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e3181a9070d","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1165038.2333064","asserted-by":"object"}]},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}